For more detail: http://einstitute.worldbank.org/ei/course/medicines-health-systems-working-toward-universal-health-coverage
The goal of the Medicines in Health Systems course is to strengthen the capacity of practitioners working toward universal health coverage in low- and middle-income country health systems to design, implement, and monitor evidence-informed pharmaceutical policy and management strategies. Specifically, after completing the course, participants will be able to:
- Explain the different roles medicines play in health systems, and the roles and responsibilities of different system actors with respect to medicines in systems.
- Illustrate the competing objectives that system stakeholders face when striving toward greater availability of and more equitable access to high quality medicines, at affordable costs for households and the system, and with appropriate use to achieve target health outcomes.
- Assess the potential of different medicines policy and management approaches to balance these competing objectives, and identify the facilitators of and barriers to success of specific strategies, in a given context
- Lay out strategies for monitoring desired and potential unintended outcomes of specific medicines policy and management strategies in a given setting.
Under the P4H Network, the Deutsche Gesellschaft für Internationale Zusammenarbeit GmbH (GIZ) supported development of the content of the Medicines in Health Systems course.
The target audience for the Medicines in Health Systems course is broad: practitioners working on health system reforms or management, primarily in low- and middle-income countries. This includes:
- Decision makers and operational staff in ministries of health, finance, and labor;
- Decision makers in health insurance and health financing organizations;
- Leaders of civil society organizations focused on different aspects of health systems;
- Leaders of public, private, and mission health care delivery systems;
- Leaders and staff of international development organizations working on health care delivery and health financing and health system reforms;
- Leaders of local and multinational generic and research-based pharmaceutical companies;
- Students enrolled in formal public health, medical, or pharmacy training programs;
- Journalists who cover the health sector.